Nathan Rich
Stock Analyst at Goldman Sachs
(1.07)
# 3,525
Out of 4,827 analysts
84
Total ratings
35.48%
Success rate
-10.16%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $17.06 | +23.09% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $161.69 | +21.22% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $15.91 | +88.56% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $7.46 | +7.24% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $17.77 | -1.52% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $253.35 | +51.96% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $12.28 | +14.01% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $18.07 | -39.13% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $180.93 | +24.36% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $489.98 | +32.66% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $67.85 | +29.70% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $15.42 | -22.18% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $68.89 | +23.39% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $9.09 | +21.01% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $325.86 | +2.80% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $385.55 | +38.76% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $17.06
Upside: +23.09%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $161.69
Upside: +21.22%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $15.91
Upside: +88.56%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $7.46
Upside: +7.24%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $17.77
Upside: -1.52%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $253.35
Upside: +51.96%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $12.28
Upside: +14.01%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $18.07
Upside: -39.13%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $180.93
Upside: +24.36%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $489.98
Upside: +32.66%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $67.85
Upside: +29.70%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $15.42
Upside: -22.18%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $68.89
Upside: +23.39%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $9.09
Upside: +21.01%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $325.86
Upside: +2.80%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $385.55
Upside: +38.76%